FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892298050> ?p ?o ?g. }

• W2892298050 endingPage "606.e8" @default.
• W2892298050 startingPage "606.e1" @default.
• W2892298050 abstract "Intrapartum magnesium sulfate administration is recommended for fetal neuroprotection in women with imminent very preterm birth. However, previous studies have not included or separately analyzed the outcomes of pregnancies with fetal growth restriction that were treated with intrapartum magnesium sulfate.We sought to evaluate the neonatal and neurodevelopmental outcomes of growth-restricted fetuses born <29 weeks' gestation and exposed to maternal intrapartum magnesium sulfate.We conducted a retrospective cohort study of infants born <29 weeks' gestation from 2010 through 2011, admitted to participating Canadian Neonatal Network units, and followed by the Canadian Neonatal Follow-up Network centers. Growth restriction was defined either as estimated fetal or actual neonatal birthweight <10th percentile according to fetal or neonatal growth standards for gestational age and sex, respectively. Infants exposed to intrapartum magnesium sulfate were compared with unexposed infants. The primary outcome was composite of death or significant neurodevelopmental impairment at 18-36 months' corrected age. Secondary outcomes were death or any neurodevelopmental impairment at 18-36 months' corrected age. Neonatal morbidities were also compared.Of the 336 growth-restricted fetuses, 112 (33%) received magnesium sulfate and of the 177 growth-restricted infants, 61 (34%) received magnesium sulfate. Administration of magnesium sulfate was at the discretion of the treating physician. Intrapartum magnesium sulfate was associated with reduced odds of composite of death or significant neurodevelopmental impairment for infants classified according to both fetal standards (adjusted odds ratio, 0.42; 95% confidence interval, 0.22-0.80) and neonatal standards (adjusted odds ratio, 0.44; 95% confidence interval, 0.20-0.98).Intrapartum administration of magnesium sulfate to women with growth-restricted fetuses born <29 weeks' gestation was associated with reduced odds of composite of death or significant neurodevelopmental impairment." @default.
• W2892298050 created "2018-09-27" @default.
• W2892298050 creator A5015558405 @default.
• W2892298050 creator A5019957473 @default.
• W2892298050 creator A5021127570 @default.
• W2892298050 creator A5032930756 @default.
• W2892298050 creator A5053034401 @default.
• W2892298050 creator A5067352224 @default.
• W2892298050 creator A5078749346 @default.
• W2892298050 creator A5083858593 @default.
• W2892298050 date "2018-12-01" @default.
• W2892298050 modified "2023-10-16" @default.
• W2892298050 title "Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses" @default.
• W2892298050 cites W1983967119 @default.
• W2892298050 cites W1986171491 @default.
• W2892298050 cites W2016988939 @default.
• W2892298050 cites W2019549525 @default.
• W2892298050 cites W2022167001 @default.
• W2892298050 cites W2031030759 @default.
• W2892298050 cites W2037026368 @default.
• W2892298050 cites W2046224781 @default.
• W2892298050 cites W2057221557 @default.
• W2892298050 cites W2061602313 @default.
• W2892298050 cites W2069390816 @default.
• W2892298050 cites W2092896998 @default.
• W2892298050 cites W2106356304 @default.
• W2892298050 cites W2127766074 @default.
• W2892298050 cites W2139737270 @default.
• W2892298050 cites W2145894451 @default.
• W2892298050 cites W2146744624 @default.
• W2892298050 cites W2171777002 @default.
• W2892298050 cites W2304517667 @default.
• W2892298050 cites W2337625431 @default.
• W2892298050 cites W2372644135 @default.
• W2892298050 cites W2528100752 @default.
• W2892298050 cites W2613165132 @default.
• W2892298050 cites W2616116784 @default.
• W2892298050 cites W2783185864 @default.
• W2892298050 cites W2783906820 @default.
• W2892298050 cites W2790845631 @default.
• W2892298050 cites W2794034096 @default.
• W2892298050 cites W2794098191 @default.
• W2892298050 cites W2886167347 @default.
• W2892298050 cites W3042607725 @default.
• W2892298050 cites W3148465273 @default.
• W2892298050 doi "https://doi.org/10.1016/j.ajog.2018.09.010" @default.
• W2892298050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240651" @default.
• W2892298050 hasPublicationYear "2018" @default.
• W2892298050 type Work @default.
• W2892298050 sameAs 2892298050 @default.
• W2892298050 citedByCount "14" @default.
• W2892298050 countsByYear W28922980502019 @default.
• W2892298050 countsByYear W28922980502020 @default.
• W2892298050 countsByYear W28922980502021 @default.
• W2892298050 countsByYear W28922980502023 @default.
• W2892298050 crossrefType "journal-article" @default.
• W2892298050 hasAuthorship W2892298050A5015558405 @default.
• W2892298050 hasAuthorship W2892298050A5019957473 @default.
• W2892298050 hasAuthorship W2892298050A5021127570 @default.
• W2892298050 hasAuthorship W2892298050A5032930756 @default.
• W2892298050 hasAuthorship W2892298050A5053034401 @default.
• W2892298050 hasAuthorship W2892298050A5067352224 @default.
• W2892298050 hasAuthorship W2892298050A5078749346 @default.
• W2892298050 hasAuthorship W2892298050A5083858593 @default.
• W2892298050 hasBestOaLocation W28922980501 @default.
• W2892298050 hasConcept C126322002 @default.
• W2892298050 hasConcept C131872663 @default.
• W2892298050 hasConcept C156957248 @default.
• W2892298050 hasConcept C172680121 @default.
• W2892298050 hasConcept C187212893 @default.
• W2892298050 hasConcept C2778376644 @default.
• W2892298050 hasConcept C2779234561 @default.
• W2892298050 hasConcept C44249647 @default.
• W2892298050 hasConcept C46973012 @default.
• W2892298050 hasConcept C54355233 @default.
• W2892298050 hasConcept C71924100 @default.
• W2892298050 hasConcept C86803240 @default.
• W2892298050 hasConceptScore W2892298050C126322002 @default.
• W2892298050 hasConceptScore W2892298050C131872663 @default.
• W2892298050 hasConceptScore W2892298050C156957248 @default.
• W2892298050 hasConceptScore W2892298050C172680121 @default.
• W2892298050 hasConceptScore W2892298050C187212893 @default.
• W2892298050 hasConceptScore W2892298050C2778376644 @default.
• W2892298050 hasConceptScore W2892298050C2779234561 @default.
• W2892298050 hasConceptScore W2892298050C44249647 @default.
• W2892298050 hasConceptScore W2892298050C46973012 @default.
• W2892298050 hasConceptScore W2892298050C54355233 @default.
• W2892298050 hasConceptScore W2892298050C71924100 @default.
• W2892298050 hasConceptScore W2892298050C86803240 @default.
• W2892298050 hasFunder F4320319966 @default.
• W2892298050 hasFunder F4320320994 @default.
• W2892298050 hasFunder F4320334506 @default.
• W2892298050 hasIssue "6" @default.
• W2892298050 hasLocation W28922980501 @default.
• W2892298050 hasLocation W28922980502 @default.
• W2892298050 hasOpenAccess W2892298050 @default.
• W2892298050 hasPrimaryLocation W28922980501 @default.
• W2892298050 hasRelatedWork W1982619745 @default.

• next